HKU Scholars Hub: Browsing DSpace

Browsing by Author Cortes, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 3 of 3

	Title	Author(s)	Issue Date
	Event-Free Survival by Residual Cancer Burden with Pembrolizumab in Early-Stage TNBC: Exploratory Analysis from KEYNOTE-522 Journal:Annals of Oncology	Pusztai, L Denkert, C O’Shaughnessy, J Cortes, J Dent, R McArthur, H Kummel, S Bergh, J Park, YH Hui, R Harbeck, N Takahashi, M Untch, M Fasching, PA Cardoso, F Zhu, Y Pan, W Tryfonidis, K Schmid, P	16-Feb-2024
	Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia Journal:Blood	Le Coutre, P Ottmann, OG Giles, F Kim, DW Cortes, J Gattermann, N Apperley, JF Larson, RA Abruzzese, E O'Brien, SG Kuliczkowski, K Hochhaus, A Mahon, FX Saglio, G Gobbi, M Kwong, YL Baccarani, M Hughes, T Martinelli, G Radich, JP Zheng, M Shou, Y Kantarjian, H	2008
	Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial Journal:The Lancet	Cortes, J Cescon, DW Rugo, HS Nowexcki, Z Im, SA Kwong, A Karantza, V Schmid, P	2020

Showing results 1 to 3 of 3